Cargando…

Networks of blood proteins in the neuroimmunology of schizophrenia

Levels of certain circulating cytokines and related immune system molecules are consistently altered in schizophrenia and related disorders. In addition to absolute analyte levels, we sought analytes in correlation networks that could be prognostic. We analyzed baseline blood plasma samples with a L...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeffries, Clark D., Perkins, Diana O., Fournier, Margot, Do, Kim Q., Cuenod, Michel, Khadimallah, Ines, Domenici, Enrico, Addington, Jean, Bearden, Carrie E., Cadenhead, Kristin S., Cannon, Tyrone D., Cornblatt, Barbara A., Mathalon, Daniel H., McGlashan, Thomas H., Seidman, Larry J., Tsuang, Ming, Walker, Elaine F., Woods, Scott W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990539/ https://www.ncbi.nlm.nih.gov/pubmed/29875399 http://dx.doi.org/10.1038/s41398-018-0158-y

Ejemplares similares

39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Perkins, Diana, et al.
Publicado: (2018)

S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING
por: Allswede, Dana, et al.
Publicado: (2018)

T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS
por: Worthington, Michelle, et al.
Publicado: (2020)

Towards a Psychosis Risk Blood Diagnostic for Persons Experiencing High-Risk Symptoms: Preliminary Results From the NAPLS Project
por: Perkins, Diana O., et al.
Publicado: (2015)

S184. MACHINE LEARNING REVEALS DEVIANCE IN NEUROANATOMICAL MATURITY PREDICTIVE OF FUTURE PSYCHOSIS IN YOUTH AT CLINICAL HIGH RISK
por: Chung, Yoonho, et al.
Publicado: (2018)

O9.8. STRESS AND COGNITIVE FUNCTION AMONG INDIVIDUALS AT CLINICAL HIGH-RISK FOR PSYCHOSIS: FINDINGS FROM THE NAPLS COHORT
por: Cullen, Alexis, et al.
Publicado: (2018)

Depression Predicts Global Functional Outcomes in Individuals at Clinical High Risk for Psychosis
por: Deng, Wisteria, et al.
Publicado: (2021)

Stressor-Cortisol Concordance Among Individuals at Clinical High-Risk for Psychosis: Novel Findings from the NAPLS Cohort
por: Cullen, Alexis E., et al.
Publicado: (2020)

Discriminatory experiences predict neuroanatomical changes and anxiety among healthy individuals and those at clinical high risk for psychosis
por: Collins, Meghan A., et al.
Publicado: (2021)

Evaluating the impact of cannabis use on thalamic connectivity in youth at clinical high risk of psychosis
por: Buchy, Lisa, et al.
Publicado: (2015)

Theory of mind, emotion recognition and social perception in individuals at clinical high risk for psychosis: Findings from the NAPLS-2 cohort
por: Barbato, Mariapaola, et al.
Publicado: (2015)

24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1
por: Velthorst, Eva, et al.
Publicado: (2018)

F32. DIFFERENCES BETWEEN YOUTH AT CLINICAL HIGH-RISK FOR PSYCHOSIS WHO DO NOT TRANSITION TO PSYCHOSIS: THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY (NAPLS-2)
por: Santesteban-Echarri, Olga, et al.
Publicado: (2018)

O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS
por: Woodberry, Kristen, et al.
Publicado: (2018)

O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY
por: Hamilton, Holly, et al.
Publicado: (2020)

Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort
por: Chung, Yoonho, et al.
Publicado: (2019)

Characterizing sustained social anxiety in individuals at clinical high risk for psychosis: trajectory, risk factors, and functional outcomes
por: Deng, Wisteria, et al.
Publicado: (2023)

The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis
por: Devoe, Daniel J., et al.
Publicado: (2023)

Insights into psychosis risk from leukocyte microRNA expression
por: Jeffries, C D, et al.
Publicado: (2016)

O3.2. BRAIN HYPERACTIVATION DURING MEMORY RETRIEVAL PRECEDES AND PREDICTS CONVERSION TO PSYCHOSIS IN INDIVIDUALS AT CLINICAL HIGH RISK
por: Cao, Hengyi, et al.
Publicado: (2018)

The association between area-level residential instability and gray matter volume changes
por: Ku, B., et al.
Publicado: (2022)

Negative Symptom Trajectories in Individuals at Clinical High Risk for Psychosis: Differences Based on Deficit Syndrome, Persistence, and Transition Status
por: Tran, Tanya, et al.
Publicado: (2023)

Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm
por: Cadenhead, Kristin S., et al.
Publicado: (2020)

F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER
por: Foss-Feig, Jennifer, et al.
Publicado: (2018)

Genetic and clinical analyses of psychosis spectrum symptoms in a large multiethnic youth cohort reveal significant link with ADHD
por: Olde Loohuis, Loes M., et al.
Publicado: (2021)

Stability of mismatch negativity event‐related potentials in a multisite study
por: Roach, Brian J., et al.
Publicado: (2020)

O5.6. ADVANCED DIFFUSION IMAGING IN PSYCHOSIS RISK: A CROSS-SECTIONAL AND LONGITUDINAL STUDY OF WHITE MATTER DEVELOPMENT
por: Di Biase, Maria, et al.
Publicado: (2020)

Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study
por: Foss-Feig, Jennifer H., et al.
Publicado: (2021)

Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization
por: Cao, Hengyi, et al.
Publicado: (2018)

Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis
por: Amir, Carolyn M., et al.
Publicado: (2023)

Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk
por: Collins, Meghan A., et al.
Publicado: (2022)

The Mini-SIPS: development of a brief clinical structured interview guide to diagnosing DSM-5 Attenuated Psychosis Syndrome and training outcomes
por: Woods, Scott W., et al.
Publicado: (2022)

The Neuroimmunology of Schizophrenia
por: Smyth, Annya M., et al.
Publicado: (2013)

Advances in Neuroimmunology
por: Gruol, Donna
Publicado: (2017)

Precision in neuroimmunology
por: Dalmau, Josep
Publicado: (2017)

Neuroimmunology Research. A Report from the Cuban Network of Neuroimmunology
por: Robinson-Agramonte, María de los Angeles, et al.
Publicado: (2018)

Neuroimmunology – the past, present and future
por: Nutma, E., et al.
Publicado: (2019)

Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications
por: Konen, Franz Felix, et al.
Publicado: (2022)

Workshop P: Neuroimmunology
Publicado: (1993)

Maximising the potential of neuroimmunology
por: Caldwell, Lindsey J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_drhucnumvam2proqd3e71jq098